Shareholder Information
Share management and Shareholder Meeting information
Q2 2024 Results In Line with Updated Guidance; $100m Share Buyback Announced
July 25 2024 Download (637KB)2024 Jefferies Global Healthcare Conference
June 5 2024 Download (905KB)Analyst Teach-in
May 23 2024 Download (4.82MB)Q1 2024 Financial Results
April 25 2024 Download (529KB)Annual Report and Accounts 2023
March 13 2024 Download (15.6MB)Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
October 10 2024Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review
October 7 2024Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder
September 4 2024Indivior Announces BARDA's First Order of OPVEE® to Combat Opioids and Aid in National Preparedness
August 26 2024Indivior Announces Q2 2024 Financial Results
July 25 2024